Double-blind Study to Evaluate the Safety and Efficacy of Antroquinonol in Mild-Moderate COVID-19 Hospitalized Patients
Clinical trial NCT04523181 · COMPLETED
Trial details
- NCT number
- NCT04523181
- Sponsor
- Golden Biotechnology Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-15
- Primary completion
- 2021-12-23
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.